📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: NewBiotics

1.1 - Company Overview

NewBiotics Logo

NewBiotics

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of drug discovery and development focused on molecules that leverage the cycle of drug resistance in cancer and infectious diseases, transforming drug resistances into therapeutic advantages.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to NewBiotics

Sophos Biotech Logo

Sophos Biotech

HQ: Italy Website
  • Description: Provider of pharmaceutical medicines and drugs for the treatment of mucositis and prostate and breast oncology.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Sophos Biotech company profile →
GSK Logo

GSK

HQ: United Kingdom Website
  • Description: Provider of pharmaceutical medicines, vaccines, and consumer healthcare products.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full GSK company profile →
HRA Pharma Logo

HRA Pharma

HQ: France Website
  • Description: Provider of drugs, devices, and services in reproductive health and endocrine diseases, offering products such as Norlevo for emergency contraception; Cicatridine for vaginitis and vaginal injury; Delidose, Divina, and Duova for hormone replacement therapy; and GyMiso for cervical ripening.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full HRA Pharma company profile →
Bristol Myers Squibb Logo

Bristol Myers Squibb

HQ: United States Website
  • Description: Provider of pharmaceuticals, engaging in the discovery, development, licensing, manufacturing, marketing, distribution and sale of therapies, including cancer immunotherapies Opdivo (nivolumab) and Yervoy (ipilimumab); anticoagulant Eliquis (apixaban); oncology treatments Revlimid (lenalidomide) and Sprycel (dasatinib); and autoimmune therapy Orencia (abatacept).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Bristol Myers Squibb company profile →
MediQuest Therapeutics Logo

MediQuest Therapeutics

HQ: United States Website
  • Description: Provider of topical pharmaceutical solutions for inflammatory and infectious diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full MediQuest Therapeutics company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for NewBiotics

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to NewBiotics

2.2 - Growth funds investing in similar companies to NewBiotics

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for NewBiotics

4.2 - Public trading comparable groups for NewBiotics

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to NewBiotics

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About NewBiotics

What does NewBiotics do?

NewBiotics is a provider of drug discovery and development focused on molecules that leverage the cycle of drug resistance in cancer and infectious diseases, transforming drug resistances into therapeutic advantages.

Who are NewBiotics's competitors?

NewBiotics's competitors and similar companies include Sophos Biotech, GSK, HRA Pharma, Bristol Myers Squibb, and MediQuest Therapeutics.

Where is NewBiotics headquartered?

NewBiotics is headquartered in United States.

How many employees does NewBiotics have?

NewBiotics has 1,000 employees 🔒.

When was NewBiotics founded?

NewBiotics was founded in 2010 🔒.

What sector and industry vertical is NewBiotics in?

NewBiotics is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for NewBiotics

Who are the top strategic acquirers in NewBiotics's sector and industry

Top strategic M&A buyers and acquirers in NewBiotics's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for NewBiotics?

Top strategic M&A buyers groups and sectors for NewBiotics include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in NewBiotics's sector and industry vertical

Which are the top PE firms investing in NewBiotics's sector and industry vertical?

Top PE firms investing in NewBiotics's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in NewBiotics's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in NewBiotics's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in NewBiotics's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to NewBiotics include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in NewBiotics's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for NewBiotics?

The key public trading comparables and valuation benchmarks for NewBiotics include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for NewBiotics for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for NewBiotics with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in NewBiotics's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for NewBiotics with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in NewBiotics's' sector and industry vertical?

Access recent funding rounds and capital raises in NewBiotics's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for NewBiotics